שולי רווח נקי Molecular Templates Inc (MTEM)

לוגו גרפי של Molecular Templates Corp (MTEM)

Molecular Templates is implementing software robots to analyze ETB platform data and automate molecule screening. The time trajectory on the GURU.Markets chart for net profitability of implementations shows that the metric level is -61.40. Efficient biomaterial logistics support profitability, however, intense competition in the toxin niche and pressure from immunotherapy leaders create significant investment risks.

רווחיות מכירות לפי רווח נקי Molecular Templates (MTEM): לתקופה 04.07.2022 - 28.12.2024

פילוחים אנליטיים ודוחות נתונים של חברת Molecular Templates Corporation (MTEM)

- שווי שוק ותחזית יעד של אנליסטים:
ניתוח מקיף של החברה:Molecular Templates
מוצר המיוצר על ידי Molecular Templates Corp

Molecular Templates has completely ceased operations due to a lack of funding and competition in oncology. The net operating margin trend reflects the share of profit after deducting all expenses. This indicator measures the efficiency of converting revenue into net income. The decline of this metric on the chart confirms the unprofitability of the business model during a recession. This asset represents a hopeless instrument with liquidated assets.